Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p>The abnormal expression of lncRNA LINC00466 (LINC00466) has been demonstrated in several tumor types. However, the expression pattern and functions of LINC00466 in glioma remain uninvestigated.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>qRT‐PCR was utilized to analyze LINC00466 in human glioma tissues and cell lines. Luciferase reporter assays were performed to explore whether YY1 could bind to the promoter region of LINC00466. CCK‐8, flow cytometry, colony‐formation, transwell migration and invasion assays were carried out to determine the involvements of INC00466 in glioma. Luciferase assays and pull‐down assays were processed for verifying the binding sites.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>We report that LINC00466 expression is increased in glioma cells and tissues. YY1 transcription factor (YY1) can bind directly to the LINC00466 promoter region. Clinical studies revealed that the elevated expression of LINC00466 is closely correlated with an advanced WHO grade (<i>p</i> = 0.008), Karnofsky Performance Status (KPS) score (<i>p</i> = 0.004) and a short overall survival (<i>p</i> = 0.0035) of glioma patients. Functional assays revealed that LINC00466 knockdown distinctly suppresses glioma cell proliferation, migration, invasion and EMT progress, and promotes apoptosis. Moreover, dual‐luciferase reporter assays indicated that LINC00466 acts as an endogenous sponge via binding to miR‐508 and decreasing its expressions. Luciferase assays and RT‐PCR assays demonstrated that checkpoint kinase 1 (CHEK1) is a target of miR‐508, and LINC00466 modulates CHEK1 levels by competing for miR‐508. LINC00466 may exhibit its anti‐oncogenic roles through targeting miR‐508/CHEK1 axis </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusions</h3><p>Our finding identified a novel glioma‐related lncRNA LINC00466, which may provide a potential novel prognostic and therapeutic target for glioma.</p></section>

SP1 induced lncRNA CASC11 accelerates the glioma tumorigenesis through targeting FOXK1 via sponging miR-498.

Long Non‑coding RNA LINC00473/miR‑195‑5p Promotes Glioma Progression Via YAP1‑TEAD1‑Hippo Signaling.

Long Noncoding RNA LINC00052 Suppressed the Proliferation, Migration and Invasion of Glioma Cells by Upregulating KLF6.

A Novel Lncrna‐linc01116 Regulates Tumorigenesis of Glioma by Targeting VEGFA

SP1-upregulated LBX2-AS1 promotes the progression of glioma by targeting the miR-491-5p/LIF axis

Knockdown of LncRNA SCAMP1 suppressed malignant biological behaviours of glioma cells via modulating miR‐499a‐5p/LMX1A/NLRC5 pathway

An Axis Involving Snai1, Microrna-128 And Sp1 Modulates Glioma Progression

The Long Noncoding Rna Zfas1 Promotes The Progression Of Glioma By Regulating The Mir-150-5p/Plp2 Axis

SP1-induced Lncrna ZFPM2 Antisense RNA 1 (ZFPM2-AS1) Aggravates Glioma Progression Via the Mir-515-5p/superoxide Dismutase 2 (SOD2) Axis

Circular RNA circSCAF11 Accelerates the Glioma Tumorigenesis through the miR-421/SP1/VEGFA Axis.

LncRNA FOXD1-AS1 acts as a potential oncogenic biomarker in glioma.

Retraction Note To: LncRNA RP11-84E24.3 Drives Tumorigenesis and Epithelial-to-mesenchymal Transition of Glioma Cells by Promoting TFAP2C-mediated Activation of SNAI1

LINC00511 knockdown suppresses glioma cell malignant progression through miR-15a-5p/AEBP1 axis

Long Intergenic Noncoding RNA 00152 Promotes Glioma Cell Proliferation and Invasion by Interacting with MiR-16

LINC00606 promotes glioblastoma progression through sponge miR-486-3p and interaction with ATP11B

Long intergenic non-coding LINC00657 regulates tumorigenesis of glioblastoma by acting as a molecular sponge of miR-190a-3p.

YY1‐mediated up‐regulation of lncRNA LINC00466 facilitates glioma progression via miR‐508/CHEK1

Upregulation of long noncoding RNA zinc finger antisense 1 enhances epithelial–mesenchymal transition in vitro and predicts poor prognosis in glioma

Upregulation of the Long Non-Coding RNA SNHG1 Predicts Poor Prognosis, Promotes Cell Proliferation and Invasion, and Reduces Apoptosis in Glioma.

A Long Noncoding Rna Zeb1-As1 Promotes Tumorigenesis and Predicts Poor Prognosis in Glioma

Long Non-Coding RNA PAXIP1-AS1 Facilitates Cell Invasion and Angiogenesis of Glioma by Recruiting Transcription Factor ETS1 to Upregulate KIF14 Expression